Core Points - VitalHub Corp. has filed a prospectus supplement for a public offering of 5,118,111 common shares at a price of $12.70 per share, aiming for gross proceeds of approximately $65 million, with an additional 767,717 shares available through an over-allotment option for about $9.75 million [1][2][3] Group 1 - The offering is expected to close on or about August 20, 2025, pending regulatory approval from the Toronto Stock Exchange [2] - The common shares will be sold in Canada and may also be offered in the United States under private placement exemptions [3] - The prospectus and its amendments are accessible through SEDAR+, and interested investors can obtain copies from Cormark Securities Inc. [4] Group 2 - VitalHub is a leading software company focused on health and human services, serving over 1,300 clients globally with a product suite that includes electronic health records and operational intelligence [7] - The company has a growth strategy that includes both organic opportunities and an aggressive M&A plan, with a workforce of over 600 employees [7]

Core Insights - VitalHub Corp. reported a significant increase in Annual Recurring Revenue (ARR), which rose by 55% year-over-year to $79.6 million [1][10] - Total revenue for the second quarter of 2025 increased by 47% year-over-year to $23.9 million [1][8] - Adjusted EBITDA also saw a substantial rise, up 50% year-over-year to $6.3 million [1][8] Financial Performance - For the three months ended June 30, 2025, revenue was $23,857,548, compared to $16,237,605 in the same period last year, marking a 47% increase [7][8] - For the six months ended June 30, 2025, total revenue reached $45,532,514, up 45% from $31,494,396 in the prior year [7][8] - Gross profit as a percentage of revenue remained stable at 81% for both Q2 2025 and Q2 2024 [8][9] Growth Drivers - The ARR growth of $28,305,511 or 55% from $51,283,570 at June 30, 2024, was driven by organic growth of $7,329,129 (14%) and acquisition growth of $18,470,000 (36%) [8][10] - The company closed significant acquisitions, including Novari Health and Induction, which are expected to enhance its product offerings in electronic referral and patient engagement solutions [3][8] Cash Position - As of June 30, 2025, VitalHub had a cash balance of $94,008,665, an increase from $56,574,904 at the end of 2024 [10][11] - The company arranged a $15 million loan for acquisition financing, which was fully repaid after the quarter-end [8][10] Strategic Outlook - VitalHub aims to continue its international expansion, supported by a robust cash position and a strong ARR [3][11] - The company is focused on integrating its recent acquisitions to build a consolidated financial profile [3][11]

Core Viewpoint - VitalHub Corp. is set to release its financial results for Q2 2025 on August 7, 2025, with a conference call scheduled for August 8, 2025, hosted by CEO Dan Matlow and CFO Brian Goffenberg [1] Company Overview - VitalHub is a leading software company focused on empowering health and human services providers globally [2] - The company's product suite includes electronic health records, operational intelligence, and workforce automation solutions, serving over 1,000 clients across the UK, Canada, and other regions [2] - VitalHub employs over 500 individuals globally and has a dedicated Innovations Lab located in Sri Lanka [2] - The company has a two-pronged growth strategy that includes targeting organic growth opportunities within its product suite and pursuing an aggressive mergers and acquisitions (M&A) plan [2]

Core Points - Vitalhub Corp. held its annual general meeting on June 27, 2025, where all director nominees were elected and MNP LLP was appointed as auditors [1][3] Voting Results - Total shares voted were 33,721,314, representing 60.45% of the total shares issued and outstanding, which is 55,784,972 [1] - Election of Directors: - Barry Tissenbaum received 27,796,480 votes (83.01%) - Roger Dent received 22,227,480 votes (66.38%) - Stephen Garrington received 33,334,105 votes (99.55%) - Dan Matlow received 33,209,025 votes (99.18%) - Francis Shen received 24,660,909 votes (73.65%) - Tony Shen received 27,960,184 votes (83.50%) [2] - Appointment of Auditors: - MNP LLP received 33,564,368 votes (99.53%) for appointment as auditors [4] Company Overview - VitalHub is a leading software company focused on health and human services, offering a product suite that includes electronic health records and operational intelligence [5] - The company serves over 1,000 clients across the UK, Canada, and other regions, and has a growth strategy that includes both organic opportunities and an aggressive M&A plan [5]

Core Insights - VitalHub Corp. reported a strong start to 2025 with significant growth in Annual Recurring Revenue (ARR) and total revenue, indicating robust business performance and strategic positioning in the health and human services software market [3][6]. Financial Performance - ARR increased by 54% year-over-year to $73.7 million as of March 31, 2025, compared to $47.8 million in the same period last year [6][7]. - Total revenue for the first quarter of 2025 was $21.7 million, reflecting a 42% increase from $15.3 million in the prior year [6][7]. - Adjusted EBITDA rose by 39% year-over-year to $5.6 million, representing 26% of total revenue [6][7]. Growth Drivers - The ARR growth was driven by organic growth of $6.7 million (14%) and acquisition growth of $16.8 million (35%) over the past year [6]. - The company ended the first quarter with a cash balance exceeding $90 million, positioning it well for future acquisitions [3][6]. Strategic Initiatives - VitalHub is pursuing a potential cash acquisition of UK-based Induction Healthcare Group PLC, valued at approximately £9.7 million ($18 million), expected to close in Q3 2025 [3][6]. - The company maintains a disciplined approach to acquisitions, focusing on opportunities that offer strategic value and improved pricing [3]. Operational Highlights - The gross profit margin was 80% for the first quarter of 2025, slightly down from 81% in the prior year [7]. - The company serves over 1,000 clients globally, with a comprehensive product suite that includes electronic health records and operational intelligence solutions [8][9].

Core Viewpoint - VitalHub Corp. is set to release its financial results for Q1 2025 on May 8, 2025, followed by a conference call on May 9, 2025, hosted by CEO Dan Matlow and CFO Brian Goffenberg [1] Company Overview - VitalHub is a leading software company focused on empowering health and human services providers globally [2] - The company offers a comprehensive product suite that includes electronic health records, operational intelligence, and workforce automation solutions, serving over 1,000 clients across the UK, Canada, and other regions [2] - VitalHub employs over 500 individuals globally and has a dedicated Innovations Lab located in Sri Lanka [2] - The company has a robust growth strategy that includes targeting organic opportunities within its product suite and pursuing an aggressive M&A plan [2]

Core Viewpoint - VitalHub Corp. has announced a cash acquisition of Induction Healthcare Group PLC, valuing Induction at approximately £9.7 million, with each shareholder entitled to receive £0.10 in cash for each share held [1] Company Overview - Induction provides software solutions that enhance care delivery and patient journeys in hospitals, allowing healthcare providers to deliver care both remotely and face-to-face [3][16] - Key products include Zesty, a patient engagement platform, and Attend Anywhere, a video consultation platform [4][5] Financial Performance - For FY24, Induction reported revenues of £14.4 million, a gross margin of 78.4%, and an adjusted EBITDA loss of £0.3 million [6] - For H1 FY25, revenues were £5.4 million, with a gross margin of 78.2% and an adjusted EBITDA loss of £0.9 million [7] Strategic Rationale - VitalHub views Induction's Zesty platform as complementary to its existing offerings, aiming to enhance product diversity and improve patient outcomes [8] - The acquisition is expected to expand VitalHub's market reach in the UK, Europe, Canada, the Middle East, and Australia [9] - Induction is anticipated to benefit from being part of a larger, well-capitalized enterprise, enabling effective implementation of strategic initiatives [10] Acquisition Details - The acquisition will be executed through a court-approved scheme of arrangement, requiring approval from Induction shareholders and the Court [11][12] - Induction's directors recommend shareholders vote in favor of the scheme, with irrevocable commitments received for approximately 44.3% of Induction's shares [13] - The transaction is expected to close by July 31, 2025, with a long stop date of September 30, 2025 [13]